SCHEMBL19767974

SCHEMBL19767974

CC1(C)c2ccccc2-c2ccc(-c3ccc4ccc5ccc(-c6ccc7ccccc7n6)nc5c4n3)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.46
RAB9A P51151 11/20 0.46
SMN1; SMN2 Q16637 8/20 0.46
KDM4E B2RXH2 6/20 0.46
ALDH1A1 P00352 4/20 0.46
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
AR P10275 6/20 0.42
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.42
MAPT P10636 5/20 0.42
LMNA P02545 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
CYP3A4 P08684 2/20 0.41
GMNN O75496 1/20 0.41
TP53 P04637 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
THPO P40225 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12393780 0.93 NPC1 (0.51) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL29756492 0.93 NPC1 (0.51) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL30466701 0.92 NPC1 (0.50) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL132323 0.91 PDK2 (0.37) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL19768037 0.89 NPC1 (0.38) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL80784 0.86 NPC1 (0.45) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL19768240 0.86 NPC1 (0.36) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL19768292 0.86 NPC1 (0.36) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL15603704 0.85 NPC1 (0.44) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL19768250 0.85 ENPP3 (0.34) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 US disclosed
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT SUN2, PAH, FARS2 NPC1 4176/4885RAB9A 1396/4885SMN1; SMN2 4613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.